Related Experiment Videos
Direct effects of intraperilymphatic reactive oxygen species generation on cochlear function
1Department of Surgery, University of Kentucky College of Medicine, Lexington 40536-0084, USA.
Hearing Research
|November 1, 1996
Summary
Reactive oxygen species (ROS) cause cochlear dysfunction. Superoxide anion, hydroxyl radical, and H2O2 significantly impaired hearing function, demonstrating ROS
Area of Science:
- Ototoxicity research
- Auditory neuroscience
- Reactive oxygen species (ROS) biology
Background:
- Reactive oxygen species (ROS) are implicated in ototoxicity, but their specific impact on cochlear function remains unclear.
- Understanding ROS-mediated cochlear damage is crucial for developing interventions against hearing loss.
Purpose of the Study:
- To investigate the specific effects of different ROS, including superoxide anion (O2-), hydroxyl radical (OH.), and hydrogen peroxide (H2O2), on cochlear function in guinea pigs.
- To determine the protective effects of ROS scavengers against ROS-induced ototoxicity.
Main Methods:
- Guinea pig cochleas were instilled with artificial perilymph (AP) as a control.
- Cochleas received H2O2, O2- generating system, or OH. generating system, with or without respective scavengers: catalase (CAT), superoxide dismutase (SOD), or deferoxamine (DEF).
- Compound action potential (CAP) threshold shifts and cochlear microphonic (CM) potential shifts were measured at various time points post-infusion.
Main Results:
- Instillation of O2- generating systems significantly increased high-frequency CAP threshold shifts compared to controls and the SOD/O2- group.
- H2O2 exposure resulted in significant CAP threshold shifts, which were attenuated by catalase (CAT).
- OH. generating systems caused significant CAP threshold shifts, reduced by deferoxamine (DEF), indicating ROS-specific ototoxicity.
Conclusions:
- Superoxide anion, hydroxyl radical, and H2O2 directly impair cochlear function, leading to high-frequency hearing loss.
- ROS scavengers like SOD, CAT, and DEF can mitigate ROS-induced ototoxicity.
- These findings highlight the significant role of ROS in cochlear dysfunction and suggest potential therapeutic targets for hearing loss prevention.